Related Experiment Video

Updated: Jun 13, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Drug resistance, epigenetics, and tumor cell heterogeneity

Timothy Hoey1

  • 1OncoMed Pharmaceuticals, Redwood City, CA 94063, USA. Tim.Hoey@oncomed.com

Science Translational Medicine
|April 23, 2010
PubMed

Insights

Cancer cells resist treatment, but chromatin changes influence drug sensitivity. Understanding these epigenetic alterations can improve combination cancer therapies.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer cell resistance to therapy is a major clinical challenge.
  • Chromatin modifications play a role in regulating gene expression and cellular responses.
  • Understanding the mechanisms of drug resistance is critical for developing effective treatments.

Purpose of the Study:

  • To investigate how changes in chromatin structure affect cancer cell sensitivity to therapeutic agents.
  • To explore the potential of targeting chromatin modifications for enhancing combination cancer therapies.

Main Methods:

  • Analysis of gene expression and chromatin accessibility in cancer cells.
  • Assessment of drug sensitivity following specific chromatin-modifying interventions.
  • Evaluation of combination therapy efficacy in preclinical models.

Main Results:

  • Specific chromatin alterations were identified that correlate with increased or decreased drug sensitivity.
  • Modulating chromatin structure demonstrated a significant impact on the effectiveness of certain chemotherapeutic agents.
  • Combination therapies guided by chromatin insights showed improved tumor response compared to single agents.

Conclusions:

  • Chromatin remodeling is a key determinant of cancer drug sensitivity.
  • Targeting epigenetic mechanisms offers promising avenues for overcoming therapeutic resistance.
  • This research provides a foundation for developing novel, chromatin-informed combination cancer treatment strategies.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.